Aspira Pathlab Fair Value
Aspira Pathlab fair value. Aspira Pathlab (ASPIRA) average fair value is ₹15.92 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹119.15 (-86.64%), fair value range ₹11.4–₹25.34. Explore ASPIRA value investing to estimate fundamental worth using multiple valuation models.
Fair Value Analysis Export
ASPIRA Fair Value vs Current Price — Valuation Summary
ASPIRA average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit ASPIRA share price.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
ASPIRA Fair Value Analysis — Data Sources & Coverage
Aspira Pathlab financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Check ASPIRA market cap trends to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
ASPIRA vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Aspira Pathlab P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Apollo Hospitals | APOLLOHOSP | 53.88 | 12.34 | ₹116,947 |
| Broach Lifecare Hospital | BROACH | - | - | ₹9 |
| Dr. Agarwal's Health Care | AGARWALEYE | 86.39 | 7.9 | ₹15,699 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
| Gujarat Kidney and Super… | GKSL | 83.47 | 5.53 | ₹1,434 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.